Press Releases
Cleveland Diagnostics, Inc. Raises Over $19 Million in Financing
February 9, 2021
Benesch represented Cleveland Diagnostics, Inc., a clinical-stage biotechnology company developing next-generation diagnostic tests for the early detection of cancers, during its Series D round of investing lead by Lyfe Capital which raised over $19 million in financing.
Funds raised will be used to expand commercialization of IsoPSA—the company’s first diagnostic test, designed to enhance early detection of prostate cancer—as well as to expand internal infrastructure and operations to support platform development for other tests, including breast and lung cancer.
The Benesch team included Sean Peppard and Ryan Williams.
Latest News
Benesch Represents Weltman, Weinberg & Reis Co., LPA in its strategic Acquisition of Nathan & Nathan, P.C., a Southeast-based Creditors Rights Law Firm
Benesch is pleased to announce that it served as legal counsel to Weltman, Weinberg & Reis Co., LPA (“Weltman”), a …
126 Benesch Attorneys Recognized in 2027 Best Lawyers® Rankings
Benesch is proud to announce that the firm has been recognized in the 2027 edition of Best Lawyers in America®. …
Benesch Partners Hanna Conger and Caitlin Kovacs Named to 2026 Benchmark Litigation 40 & Under List
Benesch is pleased to announce that Partners Hanna Conger and Caitlin Kovacs have been named to the 2026 Benchmark Litigation …
Benesch Names Jason Dirkx Chief Innovation Officer to Lead New Innovation Department, Welcomes Abby Levine as Chief Information Officer
Benesch is pleased to announce that Jason Dirkx has joined the firm as Chief Innovation Officer (CINO), a newly created role that will lead the launch of Benesch’s Innovation Department and help drive the evolution of the firm’s service delivery model for clients. As part of a coordinated investment in technology, innovation, security and governance, the firm also welcomes Abby Levine as Chief Information Officer.